S
Straumann
Leading provider of solutions in implant dentistry and dental tissue regeneration
About Straumann
In 1954, Reinhard Straumann founded the Dr. Ing. R. Straumann Research Institute AG, focusing on materials science and precision instruments. This foundation set the stage for Straumann's future in dental innovation. The company initially thrived in the field of alloys and precision instruments, which laid the groundwork for its later ventures into dental implants.
Under the leadership of Thomas Straumann, the company underwent significant transformations. In 1998, Straumann Holding AG became a publicly traded company on the Swiss exchange, marking a pivotal moment in its history. This move provided the capital necessary to expand its operations and invest in new technologies.
Throughout the early 2000s, Straumann pursued an aggressive growth strategy, marked by strategic acquisitions such as Kuros Therapeutics in 2002 and Biora in 2003. These acquisitions allowed Straumann to expand its product offerings and solidify its position in the dental industry.
Today, Straumann is recognized as a global leader in dental implants and restorative dentistry. Its journey from a small research institute to a major player in the dental field is a testament to its commitment to innovation and quality. The company's ability to adapt and grow through strategic decisions has ensured its place at the forefront of dental technology.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1954
- Headquarters
- Freiburg, Germany
- Listing
- IPO 1998
- Open positions
- 92
- Dealroom signal
- 28.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 7 companies, latest Aug 2024
- Capital deployed
- $0
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Sep 2025 | $229M | — | Undisclosed | ↗ |
| IPO✓Exit | Jul 1998 | $0 | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Straumann is 560K monthly website visits, up 47.4% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MininavidentLiestal, SwitzerlandA handheld navigation system for the precise implantation of dental implants
$5.1Mvaluation
AlliedstarPudong, China
→
GalvoSurge Dental AGWidnau, Switzerland
→
CareStackKissimmee, United StatesPractice management platform for dental groups to manage all of their software and daily operations through one platform
$140Mvaluation
PlusDentalBerlin, GermanyDoctor-led clear aligner treatment solutions provider
$124Mvaluation
Rapid ShapeHeimsheim, GermanySouth germany technology company in the field of generative rapid prototyping and rapid manufacturing systems
→
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Straumann on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Straumann’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.